BAFNAPH.NS
Bafna Pharmaceuticals Limited [BAFNAPH.NS] Stock Forecast
Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
RSI : 000
BAFNAPH.NS Stock Summary
Top 10 Correlated ETFs
BAFNAPH.NS
Top 10 Correlated Stocks
BAFNAPH.NS
In the News
BAFNAPH.NS Financial details
Company Rating
-
Market Cap
2.06B
Income
112.65M
Revenue
1.53B
Book val./share
-
Cash/share
-
Dividend
-
Dividend %
-
Employees
588
Optionable
No
Shortable
Yes
Earnings
22 May 2024
P/E
14.08
Forward P/E
-
PEG
1.22
P/S
1.52
P/B
2.94
P/C
-
P/FCF
-
Quick Ratio
1.1
Current Ratio
2.06
Debt / Equity
-
LT Debt / Equity
-
-
-
EPS (TTM)
4.76
EPS next Y
-
EPS next Q
-
EPS this Y
116.74%
EPS next Y
-
EPS next 5Y
-
EPS last 5Y
NAN%
Revenue last 5Y
21.62%
Revenue Q/Q
-30.08%
EPS Q/Q
-218.1%
-
-
-
-
SMA20
-1.95%
SMA50
-2.07%
SMA100
-3.47%
Inst Own
-
Inst Trans
-
ROA
13%
ROE
31%
ROC
0.2%
Gross Margin
32%
Oper. Margin
11%
Profit Margin
11%
Payout
-
Shs Outstand
-
Shs Float
-
-
-
-
-
Target Price
-
52W Range
75.9-124.45
52W High
-35.58%
52W Low
+6.51%
RSI
60
Rel Volume
0.31
Avg Volume
7.37K
Volume
2.25K
Perf Week
9.13%
Perf Month
-1.7%
Perf Quarter
-0.31%
Perf Half Y
-1.38%
-
-
-
-
Beta
0.502
-
-
Volatility
2.34%, 3.1%
Prev Close
-0.11%
Price
79.88
Change
4.4%
Company Profile
- Volume Average 7.37K
- Market Capitalization 2.06B
- Employee 588
- CEO Mr. Bansilal Mahaveer Chand Bafna
- Headquarters Chennai,IN
- IPO Date 2012-11-12
-
Website
https://www.bafnapharma.com 
Bafna Pharmaceuticals Limited manufactures and sells finished pharmaceutical formulations in India. The company provides delayed and sustained release, chewable, and orally disintegrating tablets. It also exports its products. Bafna Pharmaceuticals Limited was founded in 1981 and is based in Chennai, India.
